<HashMap><database>biostudies-literature</database><scores><citationCount>0</citationCount><reanalysisCount>0</reanalysisCount><viewCount>47</viewCount><searchCount>0</searchCount></scores><additional><omics_type>Unknown</omics_type><volume>12</volume><submitter>Li D</submitter><pubmed_abstract>&lt;h4>Objective&lt;/h4>To evaluate the clinical effect of mild stimulation with letrozole on pregnancy outcomes in ovulatory women undergoing frozen embryo transfer (FET) compared to natural cycle.&lt;h4>Design&lt;/h4>Retrospective observational study.&lt;h4>Setting&lt;/h4>Tertiary care academic medical center.&lt;h4>Population&lt;/h4>A total of 6,874 infertile women with regular menstrual cycles (21-35 days) met the criteria for this study in the period from 2013 to 2020.&lt;h4>Methods&lt;/h4>All patients who were prepared for and underwent FET were divided into two groups: a modified natural cycle (NC) group (n=3,958) and a letrozole cycle group (n=2,916).&lt;h4>Main outcome measures&lt;/h4>The primary outcome of the study was clinical pregnancy rate. Secondary outcome measures were endometrial thickness, rates of implantation, positive HCG test, live birth, early miscarriage and ectopic pregnancy.&lt;h4>Results&lt;/h4>The clinical pregnancy rate was not statistically different between the modified NC-FET group and the letrozole-FFT group before (crude OR 0.99, 95% CI 0.90-1.09, P=0.902>0.05) and after propensity score matching (PSM) (crude OR 1.01, 95% CI 0.91-1.12, P=0.870>0.05). After multivariable logistic regression analysis, the clinical pregnancy rate remained insignificant before (adjusted OR 1.00, 95% CI 0.91-1.10, P=0.979>0.05) and after matching (adjusted OR 1.00, 95% CI 0.89-1.11, P=0.936>0.05), respectively. Similarly, in the crude and adjusted analysis, the positive HCG test, implantation, live birth and early miscarriage rates were also comparable in the letrozole-FFT group and modified NC-FET group before and after matching. Furthermore, the endometrial thickness of letrozole-FFT group was similar to that of modified NC-FET group with adjusted analysis.&lt;h4>Conclusion&lt;/h4>Our observation suggests that mild stimulation with letrozole could produce similar pregnancy outcomes in ovulatory patients who undergo FET when compared with a natural cycle.</pubmed_abstract><journal>Frontiers in endocrinology</journal><pagination>677689</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8493067</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Frozen Embryo Transfer in Mildly Stimulated Cycle With Letrozole Compared to Natural Cycle in Ovulatory Women: A Large Retrospective Study.</pubmed_title><pmcid>PMC8493067</pmcid><pubmed_authors>Cai R</pubmed_authors><pubmed_authors>Chen Q</pubmed_authors><pubmed_authors>Li D</pubmed_authors><pubmed_authors>Huang J</pubmed_authors><pubmed_authors>Lu X</pubmed_authors><pubmed_authors>Khor S</pubmed_authors><pubmed_authors>Kuang Y</pubmed_authors><pubmed_authors>Lyu Q</pubmed_authors><view_count>47</view_count></additional><is_claimable>false</is_claimable><name>Frozen Embryo Transfer in Mildly Stimulated Cycle With Letrozole Compared to Natural Cycle in Ovulatory Women: A Large Retrospective Study.</name><description>&lt;h4>Objective&lt;/h4>To evaluate the clinical effect of mild stimulation with letrozole on pregnancy outcomes in ovulatory women undergoing frozen embryo transfer (FET) compared to natural cycle.&lt;h4>Design&lt;/h4>Retrospective observational study.&lt;h4>Setting&lt;/h4>Tertiary care academic medical center.&lt;h4>Population&lt;/h4>A total of 6,874 infertile women with regular menstrual cycles (21-35 days) met the criteria for this study in the period from 2013 to 2020.&lt;h4>Methods&lt;/h4>All patients who were prepared for and underwent FET were divided into two groups: a modified natural cycle (NC) group (n=3,958) and a letrozole cycle group (n=2,916).&lt;h4>Main outcome measures&lt;/h4>The primary outcome of the study was clinical pregnancy rate. Secondary outcome measures were endometrial thickness, rates of implantation, positive HCG test, live birth, early miscarriage and ectopic pregnancy.&lt;h4>Results&lt;/h4>The clinical pregnancy rate was not statistically different between the modified NC-FET group and the letrozole-FFT group before (crude OR 0.99, 95% CI 0.90-1.09, P=0.902>0.05) and after propensity score matching (PSM) (crude OR 1.01, 95% CI 0.91-1.12, P=0.870>0.05). After multivariable logistic regression analysis, the clinical pregnancy rate remained insignificant before (adjusted OR 1.00, 95% CI 0.91-1.10, P=0.979>0.05) and after matching (adjusted OR 1.00, 95% CI 0.89-1.11, P=0.936>0.05), respectively. Similarly, in the crude and adjusted analysis, the positive HCG test, implantation, live birth and early miscarriage rates were also comparable in the letrozole-FFT group and modified NC-FET group before and after matching. Furthermore, the endometrial thickness of letrozole-FFT group was similar to that of modified NC-FET group with adjusted analysis.&lt;h4>Conclusion&lt;/h4>Our observation suggests that mild stimulation with letrozole could produce similar pregnancy outcomes in ovulatory patients who undergo FET when compared with a natural cycle.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2024-02-15T17:31:06.788Z</modification><creation>2022-02-11T12:00:53.663Z</creation></dates><accession>S-EPMC8493067</accession><cross_references><pubmed>34630318</pubmed><doi>10.3389/fendo.2021.677689</doi></cross_references></HashMap>